Literature DB >> 11036036

Antibiotic susceptibility pattern of Mycobacterium marinum.

A Aubry1, V Jarlier, S Escolano, C Truffot-Pernot, E Cambau.   

Abstract

In vitro activities of 17 antibiotics against 53 clinical strains of Mycobacterium marinum, an atypical mycobacterium responsible for cutaneous infections, were determined using the reference agar dilution method. Rifampin and rifabutin were the most active drugs (MICs at which 90% of the isolates tested were inhibited [MIC(90)s], 0.5 and 0.6 microgram/ml, respectively). MICs of minocycline (MIC(90), 4 microgram/ml), doxycycline (MIC(90), 16 microgram/ml), clarithromycin (MIC(90), 4 microgram/ml), sparfloxacin (MIC(90), 2 microgram/ml), moxifloxacin (MIC(90), 1 microgram/ml), imipenem (MIC(90), 8 microgram/ml), sulfamethoxazole (MIC(90), 8 microgram/ml) and amikacin (MIC(90), 4 microgram/ml) were close to the susceptibility breakpoints. MICs of isoniazid, ethambutol, trimethoprim, azithromycin, ciprofloxacin, ofloxacin, and levofloxacin were above the concentrations usually obtained in vivo. For each drug, the MIC(50), geometric mean MIC, and modal MIC were very close, showing that all the strains had a similar susceptibility pattern. Percent agreement (within +/-1 log(2) dilution) between MICs yielded by the Etest method and by the agar dilution method used as reference were 83, 59, 43, and 24% for minocycline, rifampin, clarithromycin, and sparfloxacin, respectively. Reproducibility with the Etest was low, in contrast to that with the agar dilution method. In conclusion, M. marinum is a naturally multidrug-resistant species for which the agar dilution method is more accurate than the Etest for antibiotic susceptibility testing.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11036036      PMCID: PMC101616          DOI: 10.1128/AAC.44.11.3133-3136.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria.

Authors:  C N Baker; S A Stocker; D H Culver; C Thornsberry
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

Review 2.  Nontuberculous mycobacteria and associated diseases.

Authors:  E Wolinsky
Journal:  Am Rev Respir Dis       Date:  1979-01

3.  Isolation of nontuberculous mycobacteria in the United States, 1980.

Authors:  R C Good; D E Snider
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

4.  In vitro susceptibility of Mycobacterium marinum to eight antimicrobial agents.

Authors:  W J Sanders; E Wolinsky
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

5.  Application of the Etest to the antimicrobial susceptibility testing of Mycobacterium marinum clinical isolates.

Authors:  C M Flynn; C M Kelley; M S Barrett; R N Jones
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

6.  In vitro and in vivo antimycobacterial activities of a new quinolone, DU-6859a.

Authors:  H Saito; H Tomioka; K Sato; S Dekio
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

7.  In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.

Authors:  B Ji; N Lounis; C Maslo; C Truffot-Pernot; P Bonnafous; J Grosset
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

8.  Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria.

Authors:  I Guillemin; V Jarlier; E Cambau
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

9.  Structure and stereochemistry of mycolic acids of Mycobacterium marinum and Mycobacterium ulcerans.

Authors:  M Daffé; M A Lanéelle; C Lacave
Journal:  Res Microbiol       Date:  1991-05       Impact factor: 3.992

10.  Therapy of Mycobacterium marinum infections. Use of tetracyclines vs rifampin.

Authors:  S T Donta; P W Smith; R E Levitz; R Quintiliani
Journal:  Arch Intern Med       Date:  1986-05
View more
  22 in total

1.  [The fate of 20 sea breams. Mycobacterium marinum infection].

Authors:  M Schefzyk; E Richter; J H Röhrbein; T Schaefer; B Wedi; U Raap
Journal:  Hautarzt       Date:  2012-09       Impact factor: 0.751

Review 2.  Skin and Soft Tissue Infections Due to Nontuberculous Mycobacteria.

Authors:  Elizabeth Ann Misch; Christopher Saddler; James Muse Davis
Journal:  Curr Infect Dis Rep       Date:  2018-03-19       Impact factor: 3.725

3.  Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing.

Authors:  Sylvaine Bastian; Nicolas Veziris; Anne-Laure Roux; Florence Brossier; Jean-Louis Gaillard; Vincent Jarlier; Emmanuelle Cambau
Journal:  Antimicrob Agents Chemother       Date:  2010-12-06       Impact factor: 5.191

4.  The Pup-Proteasome System Protects Mycobacteria from Antimicrobial Antifolates.

Authors:  Marissa B Guzzo; Qing Li; Hoang V Nguyen; W Henry Boom; Liem Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

5.  Case of Mycobacterium marinum infection with unusual patterns of susceptibility to commonly used antibiotics.

Authors:  Nicole Parrish; Ronald Luethke; Kim Dionne; Karen Carroll; Stefan Riedel
Journal:  J Clin Microbiol       Date:  2011-03-23       Impact factor: 5.948

6.  Susceptibilities of Mycobacterium marinum to gatifloxacin, gemifloxacin, levofloxacin, linezolid, moxifloxacin, telithromycin, and quinupristin-dalfopristin (Synercid) compared to its susceptibilities to reference macrolides and quinolones.

Authors:  Martin Bråbäck; Kristian Riesbeck; Arne Forsgren
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

7.  Anti-tuberculosis effect of isoniazid scales accurately from zebrafish to humans.

Authors:  Rob C van Wijk; Wanbin Hu; Sharka M Dijkema; Dirk-Jan van den Berg; Jeremy Liu; Rida Bahi; Fons J Verbeek; Ulrika S H Simonsson; Herman P Spaink; Piet H van der Graaf; Elke H J Krekels
Journal:  Br J Pharmacol       Date:  2020-11-03       Impact factor: 8.739

8.  Broad-spectrum in vitro antibacterial activities of clay minerals against antibiotic-susceptible and antibiotic-resistant bacterial pathogens.

Authors:  Shelley E Haydel; Christine M Remenih; Lynda B Williams
Journal:  J Antimicrob Chemother       Date:  2007-12-10       Impact factor: 5.790

9.  Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis.

Authors:  Timothy P Stinear; Torsten Seemann; Paul F Harrison; Grant A Jenkin; John K Davies; Paul D R Johnson; Zahra Abdellah; Claire Arrowsmith; Tracey Chillingworth; Carol Churcher; Kay Clarke; Ann Cronin; Paul Davis; Ian Goodhead; Nancy Holroyd; Kay Jagels; Angela Lord; Sharon Moule; Karen Mungall; Halina Norbertczak; Michael A Quail; Ester Rabbinowitsch; Danielle Walker; Brian White; Sally Whitehead; Pamela L C Small; Roland Brosch; Lalita Ramakrishnan; Michael A Fischbach; Julian Parkhill; Stewart T Cole
Journal:  Genome Res       Date:  2008-04-10       Impact factor: 9.043

10.  Zebrafish Embryo Model for Assessment of Drug Efficacy on Mycobacterial Persisters.

Authors:  Susanna Commandeur; Nino Iakobachvili; Marion Sparrius; Mariam Mohamed Nur; Galina V Mukamolova; Wilbert Bitter
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.